Myriad Genetics (MYGN) Q2 2025 Earnings

6MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.05
-0.02
0.02
0.06

Details

Expected EPS
-0.054505
Actual EPS
-0.03
Surprise EPS
0.02
Surprise Percent
+44.96%

Description

Myriad Genetics (MYGN) has reported earnings of -0.03 per share for Q2 2025.

0 Comments

Share your thoughts